Επιστημονικό Προσωπικό

Επιλεγμένες Δημοσιεύσεις

Lee BH, Williams IR, Anastasiadou E, Boulton CL, Joseph SW, Amaral SM, Curley DP, Duclos N, Huntly BJ, Fabbro D, Griffin JD, Gilliland DG. FLT3 internal tandem duplication mutations induce myeloproliferative or lymphoid disease in a transgenic mouse model. Oncogene. 2005 Aug 22; [Epub ahead of print]

Wang J, Iwasaki H, Krivtsov A, Febbo PG, Thorner AR, Ernst P, Anastasiadou E, Kutok JL, Kogan SC, Zinkel SS, Fisher JK, Hess JL, Golub TR, Armstrong SA, Akashi K, Korsmeyer SJ. (2005) Conditional MLL-CBP targets GMP and models therapy-related myeloproliferative disease. EMBO J. Jan 26;24(2):368-81.

Chen J, Williams IR, Kutok JL, Duclos N, Anastasiadou E, Masters SC, Fu H, Gilliland DG. (2004) Positive and negative regulatory roles of the WW-like domain in TEL-PDGFbetaR transformation. Blood. Jul 15;104(2):535-42.

Anastasiadou E, Schwaller J. (2003) Role of constitutively activated protein tyrosine kinases in malignant myeloproliferative disorders: an update. Curr Opin Hematol. Jan;10(1):40-8. Review.

Dash AB, Williams IR, Kutok JL, Tomasson MH, Anastasiadou E, Lindahl K, Li S, Van Etten RA, Borrow J, Housman D, Druker B, Gilliland DG. (2002) A murine model of CML blast crisis induced by cooperation between BCR/ABL and NUP98/HOXA9. Proc Natl Acad Sci U S A. May 28;99(11):7622-7.

Andreasson P, Schwaller J, Anastasiadou E, Aster J, Gilliland DG. (2001) The expression of ETV6/CBFA2 (TEL/AML1) is not sufficient for the transformation of hematopoietic cell lines in vitro or the induction of hematologic disease in vivo. Cancer Genet Cytogenet. Oct 15;130(2):93-104.

Schwaller J, Anastasiadou E, Cain D, Kutok J, Wojiski S, Williams IR, LaStarza R, Crescenzi B, Sternberg DW, Andreasson P, Schiavo R, Siena S, Mecucci C, Gilliland DG. (2001) H4(D10S170), a gene frequently rearranged in papillary thyroid carcinoma, is fused to the platelet-derived growth factor receptor beta gene in atypical chronic myeloid leukemia with t(5;10)(q33;q22). Blood. Jun 15;97(12):3910-8.

Schwaller J, Parganas E, Wang D, Cain D, Aster JC, Williams IR, Lee CK, Gerthner R, Kitamura T, Frantsve J, Anastasiadou E, Loh ML, Levy DE, Ihle JN, Gilliland DG. (2000) Stat5 is essential for the myelo- and lymphoproliferative disease induced by TEL/JAK2. Mol Cell. Sep;6(3):693-704.

Kondos H, Anastasiadou E, Photopoulou A, Cary P, Aleporou-Marinou V, Pataryas T. (1995) Elevated levels of the chromosomal protein HMG 17 in chronic myelogenic leukemia. Biochem Mol Biol Int. Jul;36(4):803-9.

PubMed:

PubMed Link